Boston Scientific names Michael Jaff VP
Boston Scientific has hired Michael Jaff as VP, clinical affairs, innovation and technology. He will step into the role by January 2020. Previously, he was president of Newton-Wellesley Hospital.
Sudler London hires Faisal Ahmed
Faisal Ahmed has joined Sudler London in the newly created role of director of innovation and business transformation. Prior to this, Ahmed was a founding member of the Amazon UK start-up team.
Pryxis Oncology hires Ronald Herbst
Ronald Herbst, PhD has been appointed chief scientific officer of Pryxis Oncology. He previously served as VP, research/head, oncology R&D at MedImmune.
Dr. Paul Mendelman named interim CMO
Biopharmaceutical company Aridis Pharmaceuticals has hired Dr. Paul Mendelman as interim chief medical officer. Dr. Mendelman has previously worked at Takeda Vaccines, MedImmune and Merck. He replaces Dr. Wolfgang Dummer.
Checkmate Pharmaceuticals named Dr. Wooldridge CMO
Dr. James Wooldridge has been named chief medical officer of Checkmate Pharmaceuticals. Prior to this, he served as CMO of Aeglea BioTherapeutics.
Bhatt joins Applied Molecular Transport
Applied Molecular Transport has hired Liz Bhatt as chief business and strategy officer, a newly created position. She previously served as chief operating and business officer of Archaogen.
Client-side people moves courtesy of MM&M sister brand The PMD.
The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at firstname.lastname@example.org.